ArticleEFSA journal. European Food Safety Authority2026
Use of conversion factors for the setting of MRLs of prothioconazole.
Article in EFSA journal. European Food Safety Authority, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Use of conversion factors for the setting of MRLs of prothioconazole.EFSA journal. European Food Safety Authority · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In accordance with Article 6 of Regulation (EC) No 396/2005, the applicant Bayer AG Crop Science Division submitted a request to the competent national authority in France to use conversion factors for the setting of maximum residue levels (MRLs) for prothioconazole. The applicant did not propose modification of the existing EU MRLs for prothioconazole, as currently set in Regulation (EU) 2024/1318. The data provided in the previous EFSA outputs and submitted under the present assessment were sufficient to derive crop-specific conversion factors for all crops under consideration, except for pulses, head cabbage and flowering brassica. For onions and shallots, the submitted data are considered to support a less conservative good agricultural practice (GAP). Moreover, the data submitted were found sufficient to confirm tentative MRLs for prothioconazole in leek, Brussels sprouts, barley, oat, wheat, rye grain and in commodities of animal origin. An updated EU livestock dietary burden indicates that lower EU MRLs would be sufficient in liver, kidney and edible offal of ruminants, swine and poultry and in the fat of ruminants and swine. EFSA concluded that the existing EU uses of prothioconazole will not result in a consumer exposure exceeding the toxicological reference values and therefore are unlikely to pose a risk to consumers' health. All conclusions derived under the present assessment are considered provisional and might need to be reconsidered once the decision on the renewal of approval of prothioconazole (and related new endpoints) is implemented by the European Commission.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.